![Vials of Naloxone opioid overdose medication.](https://www.uc.edu/news/articles/2024/06/n21260235/jcr:content/image.img.cq5dam.thumbnail.500.500.jpg/1719455209133.jpg)
Study aimed at reducing opioid overdose deaths presents results
Spectrum News highlights UC researchers and HEALing Communities Study
The University of Cincinnati's John Winhusen and Caroline Freiermuth discussed the evidence-based practices implemented during the HEALing Communities Study to fight the opioid epidemic with Spectrum News.
The national effort to reduce opioid-related overdose deaths has laid the groundwork for more widely available opioid use disorder treatment, safer prescribing practices, and community-based overdose education and naloxone distribution that can save lives, according to researchers who led Ohio’s participation in the initiative.
Launched in 2019, the HEALing (Helping to End Addiction Long-Term) Communities Study (HCS) is the largest addiction prevention and treatment implementation study ever conducted. Researchers from the four participating states reported June 16 in the New England Journal of Medicine and at the College on Problems of Drug Dependence (CPDD) annual meeting that there was not a statistically significant reduction in opioid overdose death rate during the evaluation period.
“It was an enormous success," Winhusen, PhD, the Donald C. Harrison Endowed Chair in Medicine and professor and vice chair for addiction sciences in the Department of Psychiatry and Behavioral Neurosciences at UC's College of Medicine, HCS co-principal investigator for Ohio and director of the University of Cincinnati Center for Addiction Research told Spectrum News. "In Ohio, we had 18 counties participate, and in those 18 counties, we implemented over 250 evidence based practices. Most of those were focused on increasing naloxone distribution.”
Naloxone, also called by its brand name of Narcan, is the drug that can be used to reverse an opioid overdose.
Freiermuth said some of the interventions implemented or expanded by the study in the emergency department setting included implementing a screening question on opioid use and providing naloxone, wound kits, fentanyl test strips and other harm reduction supplies.
“The HEALing community study came with funds and came with some technical assistance, and we were able to utilize that to help move things forward," Freirmuth, MD, associate professor in UC's College of Medicine, told Spectrum News. "So they really were focused on screening and then they were focused on how do we treat people and how do we really initiate medications for opioid use disorder.”
Watch or read the Spectrum News story.
Read more about the study results.
Featured photo at top of bottles of injectable naloxone. Photo/iStock/PowerofForever.
Related Stories
Study aimed at reducing opioid overdose deaths presents results
June 27, 2024
![Spectrum News logo](/content/dam/refresh/uc-news/news-icons/dark/spectrum-news.png)
The University of Cincinnati's John Winhusen and Caroline Freiermuth discussed the evidence-based practices implemented during the HEALing Communities Study to fight the opioid epidemic with Spectrum News.
Cape Girardeau, Missouri news highlights UC clinical trial
February 20, 2024
KFVS-TV in Cape Girardeau, Missouri highlighted a University of Cincinnati clinical trial testing a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
Cannabis Man podcast highlights UC researcher
May 5, 2022
The University of Cincinnati's LaTrice Montgomery was a guest on the Cannabis Man podcast to discuss the current state of cannabis research.
Enquirer: Experts discuss reasons for drop in overdose deaths
April 12, 2023
The University of Cincinnati's Christine Wilder, MD, spoke with the Cincinnati Enquirer about Hamilton County data that overdose deaths in 2022 dropped for the first time in six years.
New guidelines recommend screening children 8-18 for anxiety disorders
October 13, 2022
The University of Cincinnati's Jeffrey Strawn, MD, is senior author of a new editorial in JAMA discussing new recommendations that children and adolescents ages 8 to 18 should be screened for anxiety disorders.
U.S. News & World Report: Metformin may help young patients with bipolar disorder avoid weight gain
October 31, 2023
U.S. News & World Report highlighted recent research led by the University of Cincinnati and Northwell Health that found the drug metformin can help prevent or reduce weight gain in youth taking medication to treat bipolar disorder.
Study: Strawberry consumption may reduce dementia risk for middle-aged individuals
November 2, 2023
New research from the University of Cincinnati found that daily strawberry consumption could help reduce the risk of dementia for certain middle-aged populations.
Psychiatry Advisor: PBDE exposure in utero may increase anxiety risk
December 7, 2022
Psychiatry Advisor highlighted recent University of Cincinnati research that found in utero exposure to certain flame retardant chemicals may be a risk factor for developing anxiety symptoms in early adolescence.
Forbes: Parents of color more hesitant to choose medication to treat child's anxiety disorder
December 6, 2022
Forbes highlighted research from the University of Cincinnati's Jeffrey Mills and Jeffrey Strawn examining factors behind the decision to begin or decline medication treatment for childhood anxiety disorders after cognitive behavioral therapy did not lead to improvement.
'LIVE with Kelly and Mark' highlights UC strawberry study
January 12, 2024
University of Cincinnati research on how eating strawberries can reduce dementia risk was featured in a "LIVE with Kelly and Mark" segment on superfoods to eat in 2024.